Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Paoletti

Showing results (31-40 of 145) with videos related to

Pageof 15
Sort By:
Bulletin Du Cancer|July 9, 2013
[What is the contribution of tumor response in colorectal cancer?]Jean-Baptiste Bachet, Xavier Paoletti, Laure Fournier, et al.
Nature Reviews. Clinical Oncology|February 8, 2017
Precision medicine needs randomized clinical trialsEverardo D Saad, Xavier Paoletti, Tomasz Burzykowski, et al.
Clinical Trials (London, England)|August 3, 2017
Repeated measures dose-finding design with time-trend detection in the presence of correlated toxicity dataJun Yin, Xavier Paoletti, Daniel J Sargent, et al.
Statistical Methods in Medical Research|July 7, 2017
A Poisson approach to the validation of failure time surrogate endpoints in individual patient data meta-analysesFederico Rotolo, Xavier Paoletti, Tomasz Burzykowski, et al.
European Urology|March 24, 2004
Tension-free vaginal tape and associated procedures: a case control studyArash Rafii, Xavier Paoletti, François Haab, et al.
European Journal of Cancer (Oxford, England : 1990)|February 24, 2010
Operating characteristics of two independent sample design in phase I trials in paediatric oncologyMathilde Raphaël, Marie-Cécile le Deley, Gilles Vassal, et al.
Clinical Trials (London, England)|July 8, 2020
A comparison of phase I dose-finding designs in clinical trials with monotonicity assumption violationRachid Abbas, Caroline Rossoni, Thomas Jaki, et al.
Cancer Medicine|July 15, 2021
Has tumor doubling time in breast cancer changed over the past 80 years? A systematic reviewMeryl Dahan, Delphine Hequet, Claire Bonneau, et al.
Statistics in Medicine|June 26, 2015
Dose finding with longitudinal data: simpler models, richer outcomesXavier Paoletti, Adélaïde Doussau, Monia Ezzalfani, et al.
Targeted Oncology|April 3, 2010
Current challenges for the early clinical development of anticancer drugs in the era of molecularly targeted agentsChristophe Le Tourneau, Véronique Diéras, Patricia Tresca, et al.
Pageof 15

Showing results (31-40 of 145) with videos related to

Sort By:
Pageof 15
Bulletin Du Cancer|July 9, 2013
[What is the contribution of tumor response in colorectal cancer?]Jean-Baptiste Bachet, Xavier Paoletti, Laure Fournier, et al.
Nature Reviews. Clinical Oncology|February 8, 2017
Precision medicine needs randomized clinical trialsEverardo D Saad, Xavier Paoletti, Tomasz Burzykowski, et al.
Clinical Trials (London, England)|August 3, 2017
Repeated measures dose-finding design with time-trend detection in the presence of correlated toxicity dataJun Yin, Xavier Paoletti, Daniel J Sargent, et al.
Statistical Methods in Medical Research|July 7, 2017
A Poisson approach to the validation of failure time surrogate endpoints in individual patient data meta-analysesFederico Rotolo, Xavier Paoletti, Tomasz Burzykowski, et al.
European Urology|March 24, 2004
Tension-free vaginal tape and associated procedures: a case control studyArash Rafii, Xavier Paoletti, François Haab, et al.
European Journal of Cancer (Oxford, England : 1990)|February 24, 2010
Operating characteristics of two independent sample design in phase I trials in paediatric oncologyMathilde Raphaël, Marie-Cécile le Deley, Gilles Vassal, et al.
Clinical Trials (London, England)|July 8, 2020
A comparison of phase I dose-finding designs in clinical trials with monotonicity assumption violationRachid Abbas, Caroline Rossoni, Thomas Jaki, et al.
Cancer Medicine|July 15, 2021
Has tumor doubling time in breast cancer changed over the past 80 years? A systematic reviewMeryl Dahan, Delphine Hequet, Claire Bonneau, et al.
Statistics in Medicine|June 26, 2015
Dose finding with longitudinal data: simpler models, richer outcomesXavier Paoletti, Adélaïde Doussau, Monia Ezzalfani, et al.
Targeted Oncology|April 3, 2010
Current challenges for the early clinical development of anticancer drugs in the era of molecularly targeted agentsChristophe Le Tourneau, Véronique Diéras, Patricia Tresca, et al.
Pageof 15